Differential VHL immunohistochernical staining in clear cell renal cell carcinoma: Evidence for differing mechanisms of VHL inactivation as a function of Fuhrman grade and clinical behavior

被引：0
|
作者：
Henry, P. C.
Saravanan, A.
Burry, N.
Ohh, M.
Evans, A. J.
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
685
引用
收藏
页码：152A / 152A
页数：1
相关论文
共 50 条
  • [41] Renal Cell Carcinoma with Leiomyomatous Strome Lacks VHL Alteration: A Further Feature Differentiating It from Clear Cell Renal Cell Carcinoma
    Martignoni, G.
    Brunelli, M.
    Segala, D.
    Borze, I.
    Atanesya, L.
    Savola, S.
    Barzon, L.
    Masi, G.
    Tardanico, R.
    Eble, J. N.
    Chilosi, M.
    Bohling, T.
    Cheng, L.
    Delahunt, B.
    Gobbo, S.
    Knuutila, S.
    MODERN PATHOLOGY, 2013, 26 : 232A - 232A
  • [42] Renal Cell Carcinoma with Leiomyomatous Stroma Lacks VHL Alteration: A Further Feature Differentiating It from Clear Cell Renal Cell Carcinoma
    Martignoni, G.
    Brunelli, M.
    Segala, D.
    Borze, I.
    Atanesya, L.
    Savola, S.
    Barzon, L.
    Masi, G.
    Tardanico, R.
    Eble, J. N.
    Chilosi, M.
    Bohling, T.
    Cheng, L.
    Delahunt, B.
    Gobbo, S.
    Knuutila, S.
    LABORATORY INVESTIGATION, 2013, 93 : 232A - 232A
  • [43] VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
    Athina Ganner
    Christina Gehrke
    Marinella Klein
    Lena Thegtmeier
    Tanja Matulenski
    Laura Wingendorf
    Lu Wang
    Felicitas Pilz
    Lars Greidl
    Lisa Meid
    Fruzsina Kotsis
    Gerd Walz
    Ian J. Frew
    Elke Neumann-Haefelin
    Scientific Reports, 11
  • [44] Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumourigenesis
    Clifford, SC
    Prowse, AH
    Affara, NA
    Buys, CHCM
    Maher, ER
    GENES CHROMOSOMES & CANCER, 1998, 22 (03): : 200 - 209
  • [45] Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma
    Noonan, Haley R.
    Metelo, Ana M.
    Kamei, Caramai N.
    Peterson, Randall T.
    Drummond, Iain A.
    Iliopoulos, Othon
    DISEASE MODELS & MECHANISMS, 2016, 9 (08) : 873 - 884
  • [46] Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
    Zhang, Jin
    Yan, Aiting
    Cao, Wei
    Shi, Honglei
    Cao, Kai
    Liu, Xiaowu
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [47] Computer Approach to Recognition of Fuhrman Grade of Cells in Clear-cell Renal Cell Carcinoma
    Kruk, Michal
    Osowski, Stanislaw
    Markiewicz, Tomasz
    Slodkowska, Janina
    Koktysz, Robert
    Kozlowski, Wojciech
    Swiderski, Bartosz
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2014, 36 (03): : 147 - 160
  • [48] Delayed enhancement of the peritumoural cortex in clear cell renal cell carcinoma: correlation with Fuhrman grade
    Zhang, X.
    Wang, Y.
    Yang, L.
    Li, T.
    Wu, J.
    Chang, R.
    Zhang, J.
    CLINICAL RADIOLOGY, 2018, 73 (11) : 982.e1 - 982.e7
  • [49] Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
    Jin Zhang
    Aiting Yan
    Wei Cao
    Honglei Shi
    Kai Cao
    Xiaowu Liu
    Cancer Cell International, 20
  • [50] A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma.
    Kotecha, Ritesh
    Lee, Chung-Han
    McHugh, Deaglan Joseph
    Dadoun, Chloe
    Knezevic, Andrea
    Carlo, Maria Isabel
    Feld, Emily
    Shapnik, Natalie
    Shah, Neil J.
    Feldman, Darren R.
    Motzer, Robert J.
    Voss, Martin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345